The Avoiding Cardiovascular events through COMbination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a comparison of first-line combination therapies

Author： Weder Alan B  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.2, 2005-02, pp. : 275-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination therapy is preferred for the first-line treatment of hypertension in high-risk patients

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 7, 2010-07 ,pp. : 17-20

Adis International

Access to resources Recommend Favorite

Combination Therapy as First-Line Treatment for Hypertension

By Crawford Michael H.  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 1, 2009-01 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Valsartan/Hydrochlorothiazide Fixed-dose Combination Compared with Amlodipine Monotherapy as First-line Therapy for Mild to Moderate Hypertension

By Chao CL   Lin YH   Lin LC   Lin LY   Tsai CT   Wang YC   Hwang JJ   Chen JC   Chiang FT  

The Journal of International Medical Research, Vol. 37, Iss. 2, 2009-03 ,pp. : 289-297

Field House Publishing

Access to resources Recommend Favorite

Monotherapy versus Combination Therapy as First Line Treatment of Uncomplicated Arterial Hypertension

By Ruzicka M.  

Drugs, Vol. 61, Iss. 7, 2001-01 ,pp. : 943-954

Adis International

Access to resources Recommend Favorite

Efficacy of Olmesartan Medoxomil and Hydrochlorothiazide Fixed-Dose Combination Therapy in Patients Aged 65 Years and Older with Stage 1 and 2 Hypertension or Isolated Systolic Hypertension

By Germino F. Wilford  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 5, 2012-10 ,pp. : 325-333

Adis International

Access to resources Recommend Favorite